Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Significant Increase in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 88,700 shares, an increase of 40.6% from the January 15th total of 63,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Vimian Group AB (publ) Stock Performance

VIMGF stock opened at C$3.50 on Friday. The business’s fifty day simple moving average is C$3.56 and its two-hundred day simple moving average is C$3.64. Vimian Group AB has a twelve month low of C$2.68 and a twelve month high of C$4.12.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.